Literature DB >> 21611819

[Complications of liver cirrhosis].

H Wittenburg1, U Tennert, T Berg.   

Abstract

The occurrence of complications increases the mortality in patients with cirrhosis of the liver. Therefore, early detection and treatment of complications of cirrhosis is of major importance. Following diagnosis of cirrhosis, a screening gastroscopy detects esophageal varices. Primary prevention of variceal bleeding can be initiated with β-receptor antagonists or variceal band ligation. With the first episode of ascites or the manifestation of other complications of cirrhosis such as hepatic encephalopathy and hepatorenal syndrome, a paracentesis excludes spontaneous bacterial peritonitis. Hepatorenal syndrome can be treated with a combination of vasopressors and albumine. Furthermore, occurrence of complications in patients with cirrhosis of the liver should prompt the evaluation of an indication for liver transplantation.

Entities:  

Mesh:

Year:  2011        PMID: 21611819     DOI: 10.1007/s00108-011-2853-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  21 in total

Review 1.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

2.  Uncovered transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis.

Authors:  Gennaro D'Amico; Angelo Luca; Alberto Morabito; Roberto Miraglia; Mario D'Amico
Journal:  Gastroenterology       Date:  2005-10       Impact factor: 22.682

Review 3.  Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome.

Authors:  Lise L Gluud; Kurt Christensen; Erik Christensen; Aleksander Krag
Journal:  Hepatology       Date:  2010-02       Impact factor: 17.425

4.  Early use of TIPS in patients with cirrhosis and variceal bleeding.

Authors:  Juan Carlos García-Pagán; Karel Caca; Christophe Bureau; Wim Laleman; Beate Appenrodt; Angelo Luca; Juan G Abraldes; Frederik Nevens; Jean Pierre Vinel; Joachim Mössner; Jaime Bosch
Journal:  N Engl J Med       Date:  2010-06-24       Impact factor: 91.245

5.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.

Authors:  P Sort; M Navasa; V Arroyo; X Aldeguer; R Planas; L Ruiz-del-Arbol; L Castells; V Vargas; G Soriano; M Guevara; P Ginès; J Rodés
Journal:  N Engl J Med       Date:  1999-08-05       Impact factor: 91.245

6.  Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.

Authors:  Javier Fernández; Miquel Navasa; Juliá Gómez; Jordi Colmenero; Jordi Vila; Vicente Arroyo; Juan Rodés
Journal:  Hepatology       Date:  2002-01       Impact factor: 17.425

7.  Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis.

Authors:  Vasiliki Arvaniti; Gennaro D'Amico; Giuseppe Fede; Pinelopi Manousou; Emmanuel Tsochatzis; Maria Pleguezuelo; Andrew Kenneth Burroughs
Journal:  Gastroenterology       Date:  2010-06-14       Impact factor: 22.682

8.  Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites.

Authors:  A Krag; F Bendtsen; J H Henriksen; S Møller
Journal:  Gut       Date:  2010-01       Impact factor: 23.059

9.  Primary prophylaxis of spontaneous bacterial peritonitis delays hepatorenal syndrome and improves survival in cirrhosis.

Authors:  Javier Fernández; Miquel Navasa; Ramón Planas; Silvia Montoliu; David Monfort; German Soriano; Carmen Vila; Alberto Pardo; Enrique Quintero; Victor Vargas; Jose Such; Pere Ginès; Vicente Arroyo
Journal:  Gastroenterology       Date:  2007-07-03       Impact factor: 22.682

10.  A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome.

Authors:  Arun J Sanyal; Thomas Boyer; Guadalupe Garcia-Tsao; Frederick Regenstein; Lorenzo Rossaro; Beate Appenrodt; Andres Blei; Veit Gülberg; Samuel Sigal; Peter Teuber
Journal:  Gastroenterology       Date:  2008-02-13       Impact factor: 22.682

View more
  3 in total

Review 1.  The etiology, diagnosis and prevention of liver cirrhosis: part 1 of a series on liver cirrhosis.

Authors:  Johannes Wiegand; Thomas Berg
Journal:  Dtsch Arztebl Int       Date:  2013-02-08       Impact factor: 5.594

Review 2.  [Management of decompensated liver cirrhosis in the intensive care unit].

Authors:  O Lerschmacher; A Koch; K Streetz; C Trautwein; F Tacke
Journal:  Med Klin Intensivmed Notfmed       Date:  2013-09-14       Impact factor: 0.840

3.  Changing the cause of liver cirrhosis from hepatitis B virus to fatty liver in Iranian patients.

Authors:  Behzad Hatami; Sara Ashtari; Afsaneh Sharifian; Hamideh Rahmani Seraji; Elmira Khalili; Yasin Hatami; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2017
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.